Progressive and selective changes in neurotrophic factor expression and substance P axonal transport induced by perinatal diabetes: Protective action of antioxidant treatment

Journal of Neuroscience Research

Volumn 57, Issue 4, 1999, Pages 521-528

  Germani, Elena ^b   Lesma, Elena ^b   Di Giulio, Anna Maria ^b   Gorio, Alfredo ^a,b  

^a Lab Res Pharmacol Neurodeg D   (Italy)

^b Pharmacological Laboratories   (Italy)

Author keywords

Brain derived neurotrophic factor; Diabetic neuropathy; Embryopathy; Flavonoids; IGF I; Nerve growth factor; Substance P

Indexed keywords

ALLOXAN; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; INSULIN; INSULIN ZINC SUSPENSION; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; RNA; SILIBININ; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; EMBRYO GROWTH; EMBRYOPATHY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GROWTH RETARDATION; HYPERGLYCEMIA; NERVE FIBER TRANSPORT; NERVOUS SYSTEM MALFORMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PERINATAL MORBIDITY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; TARGET ORGAN;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; AXONAL TRANSPORT; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GESTATIONAL AGE; IN SITU HYBRIDIZATION; NERVE GROWTH FACTORS; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P;

EID: 0033566741     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990815)57:4<521::AID-JNR11>3.0.CO;2-B     Document Type: Article

References (47)

1. Abbracchio MP, Cattabeni F, Di Giulio AM, Finco C, Paoletti AM, Tenconi B, Gorio A. 1991. Early alterations of Gi/Go protein-dependent transductional processes in the retina of diabetic animals. J Neurosci Res 29:196-200.
2. Akashi M, Akazawa S, Akazawa M, Trocino R, Hashimoto M, Maeda Y, Yamamoto H, Kawasaki E, Takino H, Yokota A, Nagataki S. 1991. Effects of insulin and myo-inositol on embryo growth and development during early organogenesis in streptozotocin-induced diabetic rats. Diabetes 40:1574-1579.
3. Akazawa M, Akazawa S, Hashimoto M, Akashi M, Yamasaki H, Tahara D, Yamamoto H, Yamaguchi Y, Nakanishi T, Nagataki S. 1989. Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes 38:1573-1578.
4. Akazawa S, Akazawa M, Hashimoto M, Yamaguchi Y, Kuriya N, Toyama K, Ueda Y, Nakanishi T, Mori T, Miyake S, Nagataki S. 1987. Effect of hypoglycemia on early embryogenesis in rat embryo organ culture. Diabetologia 30:791-796.
5. Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412.
6. Belai A, Lincoln J, Burnstock G. 1987. Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats. Gastroenterology 93:1034-1040.
7. Brewster WJ, Fernyhough P, Diemel LT, Mohiuddin L, Tomlison DR. 1994. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. TINS 17:321-325.
8. Brolin SE, Naeser P, Bodin B, Wentzel P, Eriksson UJ. 1986. Sorbitol may accumulate in early embryos, but does not seem to cause malformations (abstract). Diabetologia 29:522A.
9. Brown MJ, Asbury AK. 1984. Diabetic neuropathy. Ann Neurol 15:2-12.
10. Davies AM. 1994. The role of neurotrophins during successive stages of sensory neuron development. Prog Growth Factor Res 5:263-289.
11. Davies AM, Bandlow C, Heumann R, Korsching S, Rohrer H, Thoenen H. 1987. Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature 326:353-358.
12. Di Giulio AM, Tenconi B, La Croix R, Mantegazza P, Cattabeni F, Gorio A. 1989. Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal distrophy of the gut. J Neurosci Res 24:355-361.
13. Di Giulio AM, Lesma E, Gorio A. 1995. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P. J Neurosci Res 40:414-419.
14. Donadoni ML, Gavezzotti R, Borella F, Di Giulio AM, Gorio A. 1995. Experimental diabetic neuropathy. Inhibition of protein mono-ADP-ribosylation prevents reduction of substance P axonal transport. J Pharmacol Exp Ther 274:570-576.
15. Enfors P, Lee K-F, Jaenisch R. 1994. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368: 147-150.
16. Eriksson UJ, Borg LAH. 1993. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419.
17. Eriksson UJ, Naeser P, Brolin SE. 1986. Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes 35:1356-1363.
18. Faradji V, Sotelo J. 1992. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 81:402-405.
19. Feinberg AP, Vogelstein B. 1984. Addendum: a technique for radiolabeling DNA restriction endonuclease fragments to light specific activity. Anal Biochem 137:266-272.
20. Fernyhough P, Diemel LT, Brewster WJ, Tomlison DR. 1994. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience 62:337-344.
21. Freinkel N. 1980. Banting Lecture 1980: of pregnancy and progeny. Diabetes 29:1023-1035.
22. Freinkel N, Cockroft DL, Lewis NJ, German L, Akazawa S, Phillips LS, Shambaugh GE. 1986. The 1986 McCollum Award Lecture: fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. Am J Clin Nutr 44:985-986.
23. Gorio A, Di Giulio AM, Donadoni ML, Tenconi B, Germani E, Bertelli A, Mantegazza P. 1992. Early neurochemical changes in the autonomic neuropathy of the gut in experimental diabetes. Int J Clin Pharmacol Res XII:225-230.
24. Gorio A, Donadoni ML, Di Giulio AM. 1995. Nitric oxide-sensitive protein ADP-ribosylation is altered in rat diabetic neuropathy. J Neurosci Res 40:420-426.
25. Gorio A, Donadoni ML, Finco C, Borella F, Di Giulio AM. 1996a. Alterations of protein mono-ADP-ribosylation and diabetic neuropathy: a novel pharmacological approach. Eur J Pharmacol 311:21-28.
26. Gorio A, Vergani L, Malosio ML, Lesma E, Di Giulio AM. 1996b. Perinatal exposure to morphine: reactive changes in the brain after 6-hydroxydopamine. Eur J Pharmacol 303:21-26.
27. Hashimoto M, Akazawa S, Akazawa M, Akashi M, Yamamoto H, Maeda Y, Yamaguchi Y, Yamasaki H, Tahara D, Nakanishi T, Nagataki S. 1990. Effects of hyperglycemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 33:597-602.
28. Hod M, Star S, Passonneau JV, Unterman TG, Freinkel N. 1986. Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Commun 140:974-980.
29. Hosking DJ, Bennett T, Hampton JR. 1978. Diabetic autonomic neuropathy. Diabetes 27:1043-1054.
30. Levy DM, Terenghi G, GU X-H, Abraham RR, Springall DR, Polak JM. 1992. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 35:889-897.
31. Lewin GR, Ritter Am, Mendell LM. 1993. On the role of nerve growth factor in the development of myelinated nociceptors. J Neurosci 13:1896-1905.
32. Medori R, Jenich H, Autilio-Gambetti L, Gambetti P. 1988. Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models. J Neurosci 8:1814-1821.
33. Mills JL, Baker L, Goldman AS. 1979. Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes 28:292-293.
34. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, Van Allen M, Holzman I, Ober C, Peterson CM, Withiam MJ, Duckles A, Mueller-Heubach E, Polk BF. 1988. National Institute of Child Health and Human Development, Diabetes in Early Pregnancy Study: lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671-676.
35. Norido F, Canella R, Zanoni R, Gorio A. 1984. Development of diabetic neuropathy in C57BL/Ks (db/db) mouse. Exp Neurol 83:221-232.
36. Pedersen J. 1977. Congenital malformation. In: The pregnant diabetic and her newborn, 2nd ed. Copenhagen: Williams & Williams Co. p 191-197.
37. Pietrangelo A, Borella F, Casalgrandi G, Montosi G, Ceccarelli D, Gallesi D, Giovannini F, Gasparetto A, Masini A. 1995. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 109:1941-1949.
38. Robinson JP, Willars GB, Tomlison DR, Keen P. 1987. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Brain Res 426:339-428.
39. Soler NG, Walsh CH, Malins JM. 1976. Congenital malformations in infants of diabetic mothers. Q J Med 45:303-313.
40. Tomlison DR, Mayer JH. 1984. Defects of axonal transport in diabetes mellitus- A possible contribution to the aetiology of diabetic neuropathy. J Auton Pharmacol 4:59-72.
41. Tomlison DR, Robinson JP, Willars GB, Keen P. 1988. Deficient axonal transport of substance P in streptozotocin-induced diabetic rats. Effects of sorbinil and insulin. Diabetes 37;488-493.
42. Trocino R, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Kondo T, Nagataki S. 1995. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998.
43. Vergani L, Di Giulio AM, Losa M, Rossoni G, Muller EE, Gorio A. 1998. Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation. J Neurosci Res 54:840-847.
44. Vitadello M, Couraud JY, Hassig R, Gorio A, Di Giamberardino L. 1983. Axonal transport of acetylcholinesterase in the diabetic mutant mouse. Exp Neurol 82:143-147.
45. Vitadello M, Filliatreau G, Dupont JL, Hassig R, Gorio A, Di Giamberardino L. 1985. Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse. J Neurochem 45:860-868.
46. Wisden W, Morris BJ, Hunt SP. 1991. In situ hybridization with synthetic DNA probes. In: Chad, Wheal, editors. Molecular biology: a practical approach. Oxford: IRL Press. p 205-265.
47. Wright EM, Vogel KS, Davies AM. 1992. Neurotrophic factors promote the maturation of developing sensory neurons before they become dependent on these factors for survival. Neuron 9:139-150.